the medicare prescription drug, improvement, and … · 2015. 6. 26. · description of the...

THE MEDICARE PRESCRIPTIONDRUG, IMPROVEMENT, AND MODERNIZATION

ACT OF 2003

A Legislative History of P.L. 108-173

by

Mike Welsh

William S. Hein & Co., IncBuffalo, New York

2007

ISBN 978-0-8377-1409-7

Introduction, selection, and arrangement of materials© 2007 William S. Hein & Co., Inc.

All rights reserved.

Printed in the United States of America

This volume is printed on acid-free paper byWilliam S. Hein & Co., Inc.

SUMMARY TABLE OF CONTENTS

Preface

Table of Documents

In printed volumes and CD-ROM

Overview

Law

Conference Report

Committee Reports, 108th Congress



Debate, 108th Congress

Senate Amendments Submitted, 108th Congress

Debate, 108th Congress (continued)


Related Debate


In CD-ROM only

Selected Markup Documents 108th Congress

Senate Finance Committee

House Ways and Means Committee

Related to H.R. 2473



Bills, 108th Congress

Major Bills

Other Bills



Hearings, 108th Congress



Miscellaneous Remarks by Members

Presidential Remarks and Signing Statement

Government Accountability Office ReportCongressional Research Service Reports

TABLE OF DOCUMENTS

Note: The core documents, the law, reports and debate arecontained in printed volumes 1 through 5. Hearings, mark-up documents, committee prints and other material areprovided, along with the core documents, in the searchableCD-ROM included with this history.

VOLUME 1

Overview CRS Report for Congress: Overview of the Medicare Pre-scription Drug, Improvement, and Modernization Act of 2003.

Law

Doc. No. 1 Pub. Law 108-173, “Medicare Prescription Drug, Improve-ment, and Modernization Act of 2003,” signed December 8,2003.

Conference Report

Doc. No. 2 H. Rpt. 108-391 (conf. rpt. on H.R. 1), November 21, 2003.

VOLUME 2Committee Reports, 108th Congress

Doc. No. 3 H. Rpt. 108-181 (H. Rules Comm. on H. Res. 299 providingfor consideration on H.R. 1 and H.R. 2596), June 26, 2003.

Doc. No. 4 H. Rpt. 108-178 pt. 2 (H. Ways and Means Comm. on H.R.2473, Med. Mod. Prescription Drug Act), July 15, 2003.

Doc. No. 5 H. Rpt. 108-178 pt.1 (H. Energy and Commerce Comm. onH.R. 2473, Med. Mod. Prescription Drug Act), June 25,2003.

Administrator

Callout

Each entry is linked to its corrersponding document on the CD-ROM.

Doc. No. 6 H. Rpt. 108-177 (H. Ways and Means Comm. on H.R. 2351,Health Savings Accounts), June 25, 2003.

Doc. No. 7 H. Rpt. 108-74 pt. 2 (H. Energy and Commerce Comm., onH.R. 810, regulatory relief, contracting flexibility), April 29,2003.

VOLUME 3 Committee Reports, 108th Congress (continued)

Doc. No. 8 H. Rpt. 108-74 pt. 1 (H. Ways and Means Comm. on H.R.810, regulatory relief, contracting flexibility), April 11,2003.


Doc. No. 9 H. Rpt. 107-553 (H. Rules Comm. providing for considera-tion of H.R. 4954), June 26, 2002.

Doc. No. 10 H. Rpt. 107-551 pt. 1 (H. Energy and Commerce Comm. onH.R. 4984 (and H.R. 4985), Med. Mod. Prescription DrugAct, Title 1), June 26, 2002.

Doc. No. 11 H. Rpt. 107-550 pt. 1 (H. Energy and Commerce Comm., onH.R. 4988, relating to Medicare Part A), June 26, 2002.

Doc. No. 12 H. Rpt. 107-549 pt. 1 (H. Energy and Commerce Comm. onH.R. 4986, relating to Medicare Part B), June 26, 2002.

Doc. No. 13 H. Rpt. 107-547 (H. Energy and Commerce Comm. on H.R.4991, relating to Medicaid DSH payments), June 26, 2002.

Doc. No. 14 H. Rpt. 107-545 (H. Energy and Commerce Comm. on H.R.4989 relating to implementing elect. prescription drugprograms), June 26, 2002.

Doc. No. 15 H. Rpt. 107-544 (H. Energy and Commerce Comm. on H.R.4961 relating to creating a bipartisan commission on thefuture of Medicare), June 26, 2002.

Doc. No. 16 H. Rpt. 107-542 (H. Energy and Commerce Comm. on H.R.4988, relating to Medicare Benefits Admin.), June 26, 2002.

Doc. No. 17 H. Rpt. 107-541 pt. 1 (H. Energy and Commerce Comm. onH.R. 4987, Medicare Parts A and B), June 26, 2002.

Doc. No. 18 H. Rpt. 107-540 pt. 1 (H. Energy and Commerce Comm. onH.R. 4962, relating to rural health care), June 26, 2002.

Doc. No. 19 H. Rpt. 107-539 pt. 1 (H. Ways and Means Comm. on H.R.4954, relating to creating a voluntary prescription drugprogram), June 26, 2002.

VOLUME 4 Committee Reports, 107th Congress (continued)

Doc. No. 20 H. Rpt. 107-288 (H. Ways and Means Comm. on H.R. 2768relating to regulatory relief and contracting flexibility),November 13, 2001.


Doc. No. 21 H. Rpt. 106-705 (H. Rules Comm. providing for considera-tion of H.R. 4680, Medicare RX 2000 Act), June 28, 2000.

Doc. No. 22 H. Rpt. 106-703 pt. 1 (H. Ways and Means Comm. on H.R.4680, Medicare RX 2000 Act), June 27, 2000.

Debate, 108th CongressCite 2003 Congressional Record:

“149 Cong. Rec. page (daily ed., date)”

Doc. No. 23 House consideration and passage of of H. Res. 299 (rule),and H.R. 1, June 26, 27, 2003, pgs. H5952–H6256.

Doc. No. 24 Senate consideration of S. 1, June 16, 2003, pgs.S7906–7922, S7941.

Doc. No. 25 Senate consideration of S. 1, June 17, 2003, pgs.S7947–7974, 8007–8

Doc. No. 26 Senate consideration of S. 1, June 18, 2003, S8013–116,S8165.

Doc. No. 27 Senate consideration of S. 1, June 19, 2003, S8169–201,S8202–16.



Doc. No. 30 Senate consideration of S.1, June 24, 2003, S8386–426,S8429–31, S8478.

Doc. No. 31 Senate consideration of S.1, June 25, 2003, S8479–546,S8601.

Doc. No. 32 Senate consideration and passage of S. 1, June 26, 2003,S8605–33, S8635–77, S8679–85, S8686–709.

Senate Amendments Submitted, 108th Congress

Doc. No. 33 Amdts. submitted, June 18, 2003, pgs. S8161–2.




VOLUME 5 Senate Amendments Submitted, 108th Congress (continued)

Doc. No. 37 Amdts. submitted, June 24, 2003, pgs. S8446–76



Debate, 108th Congress (continued)Cite 2003 Congressional Record:


Doc. No. 40 Senate passage of H.R. 1 (text of S. 1 substituted),appointment of conferees, July 7, 2003, pgs. S8898–S8997.

Doc. No. 41 House disagreement to Senate amendment, appointment ofconferees, July 14, 2003, p. H6658.

Doc. No. 42 Conference report as printed in Cong. Rec., November 20,2003, pgs. H11877–12102.

Doc. No. 43 House passage of H. Res. 463 and conference report on H.R.1, November 21, 2003, pgs. H12174–297.

Doc. No. 44 Senate consideration of conference report on H.R. 1,November 22, 2003, pgs. S15519–69, S15574–89.

Doc. No. 45 Senate consideration of conference report on H.R. 1,November 23, 2003, pgs. S15592–644.

Doc. No. 46 Senate consideration of conference report on H.R. 1,November 24, 2003, pgs. S15670–771, S15879.

Doc. No. 47 Senate consideration and passage of conference report onH.R. 1, November 25, 2003, pgs. S15882–915.



Doc. No. 48 House consideration and passage of of H. Res. 465 and H.R.4954 (Medicare Prescription Drug and Modernization Act of2002), June 27, 2002, pgs. H4166–320.

Related Debate

Doc. No. 49 Senate consideration of S. 812 (Greater Access to Afford-able Pharmaceuticals Act), July 17, 2002, pgs. S6878–931.

Doc. No. 50 Senate consideration and passage of S. 812 (Greater Accessto Affordable Pharmaceuticals Act), July 31, 2002, pgs.S7618–51.

Doc. No. 51 House pass. H.R. 3391 (Medicare Regulatory andContracting Reform Act), December 4, 2001, pgs. H8778–801, H8814–15.



Doc. No. 52 House consideration and passage of of H. Res. 539 and H.R.4680 (Medicare RX 2000 Act:), June 28, 2000, pgs. H5300–415.

Note: The items that follow (numbers 53–177) are contained inthe full-text searchable CD-ROM included with this history.

Selected Markup Documents 108th Congress

Senate Finance Committee

Doc. No. 53 “Description of the Prescription Drug and MedicareImprovement Act of …,” May 17, 2003, Senate FinanceCommittee (http://finance.senate.gov/sitepages/leg/final%20committee%20description%206-17.pdf).

Doc. No. 54 “The Prescription Drug and Medicare Improvement Act of2003,” June 10, 2003, Senate Finance Committee (http://finance.senate.gov/sitepages/leg/Chairman%27s%20Mark%20%20Final%206-10 03.pdf).

Doc. No. 55 “Chairman’s Modifications to: The Prescription DrugModernization Act of 2003,” June 10, 2003, Senate FinanceCommittee (http://finance.senate.gov/sitepages/leg/leg061203modif.pdf).

House Ways and Means Committee


Doc. No. 56 “Medicare Prescription Drug and Modernization Act of2003,” June 19, 2003 Summary of H.R. 2473, House Waysand Means Committee (http://waysandmeans.house.gov/media/pdf/hr2473/hr2473summary.pdf).

Doc. No. 57 Amendments to the Chairman’s Amendment in the Natureof a Substitute to H.R. 2473 Adopted in Committee DuringMarkup (http://waysandmeans.house.gov/media/pdf/hr2473/hr2473adoptedamendments.pdf).

Doc. No. 58 “Amendment in the Nature of a Substitute to H.R. 2473Offered by Mr. Thomas,” June 17, 2003 (Chairman’s Mark)(http://waysandmeans.house.gov/media/pdf/hr2473/hr14782subst.pdf).


Doc. No. 59 Description of the Chairman’s Amendment I the Nature ofa Substitute to H.R. 2351, the “Health Savings AccountAvailability Act,” scheduled for a markup on June 19, 2003,Joint Committee on Taxation, June 18, 2003, JCX 63-03.

Doc. No. 60 Amendment in the Nature of a Substitute to H.R. 2351Offered by Mr. Thomas, June 18, 2003 (Chairman’s Mark)(http://waysandmeans.house.gov/media/pdf/hr2351/2351substitute.pdf).


Doc. No. 61 Joint Tax Committee, “Technical Explanation of H.R. 2596the ‘Health Savings and Affordability Act of 2003’,” aspassed by the House of Representatives June 30, 2003, JCX-66-03.


Major Bills

Doc. No. 62 H.R. 1 (enacted bill) “Medicare Prescription Drug andModernization Act of 2003,” as introduced by Rep. Hastert,June 25, 2003.

Doc. No. 63 H.R. 1 as passed House, June 27, 2003.

Doc. No. 64 H.R. 2473 (major bill) “Medicare Prescription Drug andModernization Act of 2003” as introduced by Rep. Thomas,June 16, 2003 (this legislation was folded into H.R. 1).

Doc. No. 65 H.R. 2473 as reported, June 25, July 15, 2003 (this bill wasfolded into H.R. 1).

Doc. No. 66 S. 1 (major bill) “Prescription Drug and MedicareImprov2003” as introduced by Sen. Frist, June 11, 2003.

Doc. No. 67 S. 1 as reported, June 13, 2003.

Doc. No. 68 S. 1 as passed Senate, June 27, 2003.

Other Bills

Doc. No. 69 H.R. 810 as introduced by Rep. Johnson, February 13, 2003(regulatory relief, contracting flexibility).

Doc. No. 70 H.R. 810 as reported April 11,29, 2003 (regulatory relief,contracting flexibility).

Doc. No. 71 H.R. 1382 “EMTALA Regulatory Improvement Act of2003” as introduced by Rep Shadegg, March 20, 2003.

Doc. No. 72 H.R. 2351 ‘”Health Savings Account Availability Act” asintroduced by Rep. Thomas, June 5, 2003.

Doc. No. 73 H.R. 2351 as reported, June 25, 2003.

Doc. No. 74 H.R. 2409 “Safety Net Hospital Pharmacy Access Act of2003” as introduced by Rep. Shadegg, June 10, 2003.

Doc. No. 75 H.R. 2596 “Health Savings and Affordability Act of 2003”as introduced by Rep. Thomas, June 25, 2003.

Doc. No. 76 S. 581 as introduced by Sen. Wyden, March 10, 2003 (Cit.Health Care Work. Group).

Doc. No. 77 S. 636 as introduced by Sen. Collins, March 17, 2003 (homehealth care).

Doc. No. 78 Introductory statement by Sen. Collins on S. 636, March 17,2003.

Doc. No. 79 S. 869 as introduced by Sen. Harkin, April 10, 2003(mammography).

Doc. No. 80 Introductory statement by Sen. Harkin on S. 869, April 10,2003.

Doc. No. 81 S. 942 as introduced by Sen. Brownback, April 29, 2003(rural hospital services).

Doc. No. 82 Introductory statement by Sen. Brownback on S. 942, April29, 2003.

Doc. No. 83 S. 946 as introduced by Sen. Leahy, April 29, 2003 (antitrustenforcement, drugs).

Doc. No. 84 Introductory statement by Sen. Leahy on S. 946, April 29,2003.

Doc. No. 85 S. 1095 as introduced by Sen. Sununu, May 21, 2003 (out-patient vision services).

Doc. No. 86 Introductory statement by Sen. Sununu on S. 1095, May 23,2003.

Doc. No. 87 S. 1195 as introduced by Sen. Kyl, June 5, 2003 (inpatientdrug prices).

Doc. No. 88 S. 1225 as introduced by Sen. Gregg, June 10, 2003 (accessto affordable pharmacies).


Doc. No. 89 H.R. 2768 as introduced by Rep. Johnson, August 2, 2001(regulatory relief, contracting flexibility).

Doc. No. 90 Introductory statement by Rep. Johnson on H. R. 2768, Aug.3, 2001.

Doc. No. 91 H.R. 2768 as reported November 13, 2001 (regulatory relief,contracting flexibility).

Doc. No. 92 H.R. 2802 as introduced by Rep. Paul, August 2, 2001(MSA plans).

Doc. No. 93 Introductory statement by Rep. Paul on H.R. 2802, August3, 2001.

Doc. No. 94 H.R. 3391 as introduced by Rep. Johnson, December 4,2001 (regulatory relief, contracting flexibility).

Doc. No. 95 H.R. 3391 as passed House, December 4, 2001.

Doc. No. 96 H.R. 4954 as introduced by Rep. Johnson, June 18, 2002(voluntary prescription drug program).

Doc. No. 97 Introductory statement by Rep. Tauzin on H.R. 4954 andH.R. 4962, June 20, 2002.

Doc. No. 98 H.R. 4954 as reported, June 26, 2002 (voluntary prescriptiondrug program).

Doc. No. 99 H.R. 4954 as passed House, June 28, 2002 (voluntary pre-scription drug program).

Doc. No. 100 H.R. 4962 as introduced by Rep. Tauzin, June 19, 2002(rural health care). No bill “as reported” was printed.

Doc. No. 101 H.R. 4984 as introduced by Rep. Tauzin, June 21, 2002(prescription drug benefit).

Doc. No. 102 H.R. 4984 as reported June 26, 2002 (prescription drugbenefit).

Doc. No. 103 H.R. 4985 as introduced by Rep. Tauzin, June 21, 2002(MSA program).

Doc. No. 104 H.R. 4985 as reported June 26, 2002 (MSA program).

Doc. No. 105 H.R. 4986 as introduced by Rep. Tauzin, June 21, 2002(payments outpatient services).

Doc. No. 106 H.R. 4986 as reported June 26, 2002 (payments outpatientservices) .

Doc. No. 107 H.R. 4987 as introduced by Rep. Tauzin, June 21, 2002(home health care). No bill “as reported” was printed.

Doc. No. 108 H.R. 4988 as introduced by Rep. Tauzin, June 21, 2002(Med. Ben. Admin.) No bill “as reported” was printed.

Doc. No. 109 H.R. 4989 as introduced by Rep. Tauzin, June 21, 2002(elective prescription drug program grants).

Doc. No. 110 H.R. 4989 as reported June 26, 2002 (elective prescriptiondrug program grants).

Doc. No. 111 H.R. 4991 as introduced by Rep. Tauzin, June 21, 2002(revise hospital payments).

Doc. No. 112 H.R. 4991 as reported June 26, 2002 (revise hospitalpayments).

Doc. No. 113 H.R. 5019 as introduced by Rep. Rangel, June 26, 2002(Democratic alternative bill, prescription drug benefit).

Doc. No. 114 Introductory statements by Reps. Rangel, Dingell and Starkon H.R. 5019, June 27, 2002.

Doc. No. 115 S. 812 as introduced by Sens. Schumer and McCain, May 1,2001 (access to affordable pharmacies).

Doc. No. 116 Colloquies between Sens. Stabenow, Schumer, Kennedy, etal on S. 812, May 1 and 2, 2002.

Doc. No. 117 S. 812 as reported July 11, 2002 (access to affordablepharmacies).

Doc. No. 118 S. 812 as passed Senate, July 31, 2002 (access to affordablepharmacies).

Doc. No. 119 S. 357 as introduced by Sen. Breaux, February 15, 2001(Medicare improvement).

Doc. No. 120 S. 358 as introduced by Sen. Breaux, February 15, 2001(prescription drug benefit).


Doc. No. 121 S. 1895 as introduced by Sen. Breaux, November 9, 1999(Medicare improvement).

Doc. No. 122 Introductory statement by Sen. Breaux on S. 1895,November 9, 1999.

Doc. No. 123 H.R. 4680 as introduced by Rep. Thomas, June 15, 2000(voluntary prescription drug program).

Doc. No. 124 H.R. 4680 as reported, June 15, 27, 2000 (voluntary pre-scription drug program).

Doc. No. 125 H.R. 4680 as passed House, June 28, 2000 (voluntary pre-scription drug program).


Doc. No. 126 “President’s FY 2004 Budget for U.S. Dept of HHS,”Hearing Before the Committee on Ways and Means, Houseof Representatives, February 6, 2003, Ser. 108-2.

Doc. No. 127 “Medicare Regulatory and Contracting Reform,” HearingBefore the Subcommittee on Health of the Committee onWays and Means, House of Representative, February 13,2003, Ser. 108-4.

Doc. No. 128 “Eliminating Barriers to Chronic Care Management inMedicare,” Hearing Before the Subcommittee on Health ofthe Committee on Ways and Means, House of Represen-tative, February 25, 2003, Ser. 108-6.

Doc. No. 129 “Medpac Report on Medicare Payment,” Hearing Before theSubcommittee on Health of the Committee on Ways andMeans, House of Representative, March 6, 2003, Ser. 108-14.

Doc. No. 130 “Examining the Administration’s Fiscal Year 2004 HealthCare Priorities,” Committee on Finance, United StatesSenate, February 27, 2003, S. Hrg. 108-118.

Doc. No. 131 “Purchasing Health Care Services in a CompetitiveEnvironment,” Committee on Finance, United States Senate,April 3, 2003, S. Hrg. 108-111.

Doc. No. 132 “Designing a Twenty-First Cent. Medicare PrescriptionDrug Benefit,” Hearing Before the Subcommittee on Health,Committee on Commerce, House of Representatives, April8, 2003, Ser. 108-25.

Doc. No. 133 “”Examining the House and Senate Versions of the “GreaterAccess to Afford. Pharmaceuticals Act,”“ Hearing Beforethe Committee on the Judiciary, United States Senate,August 1, 2003, Ser. J-108-34, S. Hrg. 108-390.

Doc. No. 134 “Strengthening and Improving Medicare,” Hearing Beforethe Subcommittee on Health, Committee on Commerce,House of Representatives, April 9, 2003, Ser. 108-22.

Doc. No. 135 “Medicare Cost-Sharing and Medigap,” Hearing Before theSubcommittee on Health of the Committee on Ways andMeans, House of Representative, May 1, 2003, Ser 108-8.

Doc. No. 136 “Strengthening and Improving the Medicare Program,”Committee on Finance, United States Senate, June 6, 2003,S. Hrg. 108-339.


Doc. No. 137 “Medicare Reform: Prov. Prescription Drug Coverage forSeniors,” Hearing Before the Subcommittee on Health,Committee on Commerce, House of Representatives,February 15, 2001, Ser.10

Doc. No. 138 “Medicare Reform,” Hearing Before the Subcommittee onHealth of the Committee on Ways and Means, House ofRepresentatives, February 28, 2001, Ser. 107-4.

Doc. No. 139 Bush Administration’s Health and Welfare Priorities,”Hearing Before the Subcommittee on Health of the Commit-tee on Ways and Means, House of Representatives, March14, 2001, Ser. 107-11.

Doc. No. 140 “Second in Series on Medicare Reform: Bring. Reg. Reliefto Beneficiaries” Hearing Before the Subcommittee onHealth of the Committee on Ways and Means, House ofRepresentatives, March 15, 2001, Ser. 107-12.

Doc. No. 141 “Third in Series on Medicare Reform: Laying Groundworkfor an RX Drug Benefit,” Hearing Before the Subcommitteeon Health of the Committee on Ways and Means, House ofRepresentatives March 27, 2001, Ser. 107-21.

Doc. No. 142 “Social Security and Medicare Trustees’ 2001 AnnualReports,” Joint Hearing Before the Committee on Ways andMeans, House of Representatives and Committee onFinance, United States Senate, March 20, 2001, Ser. 107-16.

Doc. No. 143 “Medicare Solvency,” Hearing Before the Committee onWays and Means, House of Representatives, March 20,2001, Ser. 107-17.

Doc. No. 144 “Fourth in Series on Medicare Reform: Medicare + Choice:Lessons for Reform,” Hearing Before the Committee onWays and Means, House of Representatives March 20, 2001,May 1, 2001, Ser. 107-20.

Doc. No. 145 “Fifth in Series on Medicare Reform: Strengthening Medi-care: Mod. Beneficiary Cost Sharing,” Hearing Before theSubcommittee on Health of the Committee on Ways andMeans, House of Representatives, May 9, 2001, Ser. 107-21.

Doc. No. 146 “Medicare Reform: Providing Prescription Drug Coveragefor Seniors,” Hearing Before the Subcommittee on Health,Committee on Commerce, House of Representatives, May16, 2001, Ser. 107-28.

Doc. No. 147 “Has Medicare + Choice Reduced Variation in the Premiumsand Benefits Offered by Participating Health Plans? A Rev. ofMedicare + Choice Plan Payment Methodology,” HearingBefore the Subcommittee on Health, Committee on Com-merce, House of Representatives, May 31, 2001, Ser. 107-39.

Doc. No. 148 “Rural Health Care in Medicare,” Hearing Before the Sub-committee on Health of the Committee on Ways and Means,House of Representatives, June 12, 2001, Ser. 107-33.

Doc. No. 149 “Medicare Reform: Modernizing Medicare and Merging.Parts. A and B,” Hearing Before the Subcommittee onHealth, Committee on Commerce, House of Representatives,June 14, 2001, Ser. 107-40.

Doc. No. 150 Administration’s Principles to Strengthen and ModernizeMedicare,” Hearing Before the Subcommittee on Health ofthe Committee on Ways and Means, House of Representa-tives, July 19, 2001, Ser. 107-39.

Doc. No. 151 “Modernizing Medicare,” Hearing Before the Subcommitteeon Health, Committee on Commerce, House of Representa-tives, July 26, 2001, Ser. 107-53.

Doc. No. 152 H.R. 2768, “Medicare Regulatory and Contracting ReformAct of 2002,” Hearing Before the Subcommittee on Healthof the Committee on Ways and Means, House of Represen-tatives, September 25, 2001, Ser. 107-45.

Doc. No. 153 “Status of Medicare + Choice Program,” Hearing Before theSubcommittee on Health of the Committee on Ways andMeans, House of Representatives December 4, 2001, Ser.107-49.

Doc. No. 154 “President’s 2003 Budget Proposals Featuring HHS Secre-tary Thompson,” Hearing Before the Committee on Waysand Means, House of Representatives February 6, 2002, Ser.107-55.

Doc. No. 155 “Medicare Payment Policy: Ensuring Stability and AccessThrough Physician Payments.” Hearing Before the Subcom-mittee on Health, Committee on Commerce, House of Rep-resentatives, February 14, 2002, Ser. 107-91.

Doc. No. 156 “Physician Payments,” Hearing Before the Subcommittee onHealth of the Committee on Ways and Means, House ofRepresentatives, February 28, 2002, Ser. 107-70.

Doc. No. 157 “Administration’s. FY 2003 Budget Proposal. for Presc.Drugs,” Hearing before the Committee on Finance, UnitedStates Senate, March 7, 2002, S. Hrg. 107-430.

Doc. No. 158 “Health Quality and Medical Errors,” Hearing Before theSubcommittee on Health of the Committee on Ways andMeans, House of Representatives, March 7, 2002, Ser.107-76.

Doc. No. 159 “Reimbursement and Access to Presc. Drugs UnderMedicare Part B,” Hearing before the Subcommittee onHealth Care of the Committee on Finance, United StatesSenate March 14, 2002, S. Hrg. 107-684.

Doc. No. 160 “Medicare Supplemental Insurance,” Hearing Before theSubcommittee on Health of the Committee on Ways andMeans, House of Representatives, March 14, 2002, Ser. 107-60.

Doc. No. 161 “Medicare Modernization: Examining Federal EmployeeHealth Benefits Program as a Model for Seniors,” HearingBefore the Subcommittee on Health of the Committee onWays and Means, House of Representatives, March 20,2002, Ser. 107-105.

Doc. No. 162 “Promoting Disease Management in Medicare,” HearingBefore the Subcommittee on Health of the Committee onWays and Means, House of Representatives, April 16, 2002,Ser 107-80.

Doc. No. 163 “Integrating Prescription Drugs into Medicare,” HearingBefore the Committee on Ways and Means, House ofRepresentatives, April 17, 2002, Ser. 107-65.

Doc. No. 164 “Medicare’s Geographic Cost Adjustors,” Hearing Beforethe Subcommittee on Health of the Committee on Ways andMeans, House of Representative, July 23, 2002, Ser 107-85.

Doc. No. 165 “Medicare Payments for Currently Covered PrescriptionDrugs,” Hearing Before the Subcommittee on Health of theCommittee on Ways and Means, House of Representative,October 3, 2002, Ser 107-84.


Doc. No. 166 “Prescription Drugs: What We Know and Don’t Know AboutSeniors’ Access to Coverage,” Hearings Before the Subcom-mittee on Health, Committee on Commerce, House of Repre-sentatives, September 28, October 4, 1999, Ser. 106-73.

Doc. No. 167 “Seniors’ Access to Prescription Drug Benefits,” HearingBefore the Subcommittee on Health of the Committee onWays and Means, House of Representatives, February 15,2000, Ser. 106-100.

Doc. No. 168 “Seniors’ Access to Affordable Prescription Drugs: Modelsfor Reform,” Hearing Before the Subcommittee on Health,Committee on Commerce, House of Representatives,February 16, 2000, Ser. 106-92

Doc. No. 169 “Administration’s. Presc. Drug Proposal,” Hearing Beforethe Subcommittee on Health of the Committee on Ways andMeans, House of Representatives, May 11, 2000, Ser. 106-104.

Doc. No. 170 “Legislation to Cover Prescription Drugs Under Medicare,”Hearing Before the Committee on Ways and Means, Houseof Representatives, June 13, 2000, Ser. 106-113.

Doc. No. 171 “Prescription Drugs: Mod. Medicare for the 21st Century,”Hearing Before the Subcommittee on Health, Committee onCommerce, House of Representatives, June 14, 2000,Ser.106-110.

Miscellaneous Remarks by Members

Cite 2003 Congressional Record: “149 Cong. Rec. page (daily ed., date)”

Doc. No. 172 Miscellaneous remarks by members from the CongressionalRecord, 108th Congress.

Presidential Remarks and Signing Statement

Doc. No. 173 Remarks on Signing the Medicare Prescription Drug,Improvement, and Modernization Act of 2003, December 8,2003, Vol. 39, No. 49, Weekly Compilation of PresidentialDocuments pgs. 1771–73.

Doc. No. 174 Statement on Signing the Medicare Prescription Drug,Improvement, and Modernization Act of 2003, December 8,2003,Vol. 39, No. 49, Weekly Compilation of PresidentialDocuments p. 1773.

Government Accountability Office Report

Doc. No. 175 GAO-03-912, Prescription Drug Discount Cards: SavingsDepend on Pharmacy and Type of Card Used, September2003, September 2003. United States General AccountingOffice, Washington, D.C.

Congressional Research Service Reports

Doc. No. 176 CRS RL31525—Medicare: Beneficiary Cost-Sharing UnderPrescription Drug Legislation, July 25, 2003.

Doc. No. 177 CRS RL31992—Medicare Prescription Drug Provisions ofS.1 as passed the Senate and H.R.1 as passed the House, July11, 2003.